Trevi Therapeutics Inc (TRVI)
Healthcare
Biotechnology
18.30 $
-0.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Trevi Therapeutics Inc (TRVI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -42 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -11 | -8.0 | -18 | -23 | -29 | -29 | -28 | -32 | -38 | -42 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | |
| 0.0 | 0.2 | 0.5 | 1.1 | 2.4 | 2.5 | 2.3 | 2.2 | 3.6 | 5.2 | |
| 0.1 | 2.0 | 2.7 | 1.3 | 2.4 | 2.8 | 2.3 | – | – | – | |
| -1.5 | 0.7 | -0.6 | 1.6 | 1.1 | 1.5 | -1.2 | -3.8 | 6.8 | -3.5 | |
| 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | |
| 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | -107 | -107 | 59 | -22 | -94 | |
| 0.0 | 0.0 | 0.0 | 2.2 | – | – | – | – | – | – | |
| 0.0 | 30 | -1.5 | -1.2 | -0.3 | – | 117 | – | – | – | |
| 8.6 | -8.3 | -4.8 | 14 | 14 | -5.8 | -5.9 | -9.5 | -0.1 | 0.0 | |
| 8.6 | 22 | 0.0 | 73 | 17 | 21 | 111 | -7.9 | 61 | 121 | |
| -2.6 | 14 | -15 | 50 | -12 | -8.2 | -24 | 20 | 1.7 | -15 | |
| -11 | -8.0 | -18 | -23 | -29 | -29 | -28 | -32 | -38 | -42 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.